EXTENDED INTERVAL DOSING OF OCRELIZUMAB REDUCES RISK OF DEVELOPING HYPOGAMMAGLOBULINAEMIA

被引：2

作者：

Allen, Christopher ^{[1
]}

Russell, Melanie ^{[2
]}

Pendlebury, Jessica ^{[3
]}

Vollmer, Brandi ^{[4
]}

Moswela, Olivia ^{[5
]}

Raza, Pranee-Ta ^{[6
]}

Garjani, Afagh

Abdel-Fahim, Rasha ^{[7
]}

Tallantyre, Emma ^{[8
]}

Evangelou, Nikos ^{[1
]}

机构：

[1] Univ Nottingham, Nottingham, England

[2] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England

[3] Salford Royal NHS Fdn Trust, Salford, Lancs, England

[4] Univ Colorado, Dept Neurol, Boulder, CO USA

[5] Oxford Univ Hosp NHS Fdn Trust, Oxford, England

[6] Cleveland Clin, Cleveland, OH USA

[7] Nottingham Univ Hosp NHS Trust, Nottingham, England

[8] Cardiff Univ, Div Psychol Med & Clin Neurosci, Cardiff, Wales

来源：

关键词：

D O I：

10.1136/jnnp-2022-abn2.26

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：1